Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held on Friday, February 5, 2021, considered and approved the following proposals: Appointment of Pramod Yadav as Non-executive Non-independent Director of the Company effective from February 5, 2021. Brief profile of Yadav is given as Annexure-A to this letter. Yadav is not related to any Director of the Company; and resignation of Rajesh Kumar Srivastava and Anant Pande as Director and Whole-time Director of the Company effective from the close of business hours of February 5, 2021. The above change in composition of the Board of Directors of the Company is on account of demerger of the Life Science Ingredients business of the Company into the Resulting Company, Jubilant Ingrevia, pursuant to the Composite Scheme of Arrangement.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1783.55 |
| Dr. Reddys Lab | 1277.80 |
| Cipla | 1400.70 |
| Zydus Lifesciences | 1088.90 |
| Lupin | 2268.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: